{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:15:40Z","timestamp":1790720140195,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,22]]},"DOI":"10.7759\/cureus.65132","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T21:44:30Z","timestamp":1721684670000},"source":"Crossref","is-referenced-by-count":1,"title":["Complex Factors in Hydrocephalus Development in Tuberous Sclerosis Complex: A Case Report of Subependymal Giant Cell Astrocytoma"],"prefix":"10.7759","author":[{"given":"Hajime","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Numoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayataka","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.08.017","article-title":"Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012","volume":"49","author":"Roth J","year":"2013","unstructured":"Roth J, Roach ES, Bartels U, et al.. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol. 2013, 49:439-44. 10.1016\/j.pediatrneurol.2013.08.017","journal-title":"Pediatr Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02160-5","article-title":"Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility","volume":"21","author":"Tomoto K","year":"2021","unstructured":"Tomoto K, Fujimoto A, Inenaga C, et al.. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility. BMC Neurol. 2021, 21:139. 10.1186\/s12883-021-02160-5","journal-title":"BMC Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-017-0077-4","article-title":"Clinical and imaging features of subependymal giant cell astrocytoma: report of 20 cases","volume":"3","author":"Mei GH","year":"2017","unstructured":"Mei GH, Liu XX, Zhou P, Shen M. Clinical and imaging features of subependymal giant cell astrocytoma: report of 20 cases. Chin Neurosurg J. 2017, 3:14-6. 10.1186\/s41016-017-0077-4","journal-title":"Chin Neurosurg J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000531210","article-title":"A comparison of clinical outcomes for subependymal giant cell astrocytomas treated with laser interstitial thermal therapy, open surgical resection, and mTOR inhibitors","volume":"58","author":"Boop S","year":"2023","unstructured":"Boop S, Bonda D, Randle S, et al.. A comparison of clinical outcomes for subependymal giant cell astrocytomas treated with laser interstitial thermal therapy, open surgical resection, and mTOR inhibitors. Pediatr Neurosurg. 2023, 58:150-9. 10.1159\/000531210","journal-title":"Pediatr Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03487-8","article-title":"The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)","volume":"147","author":"Weidman DR","year":"2020","unstructured":"Weidman DR, Palasamudram S, Zak M, et al.. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). J Neurooncol. 2020, 147:731-6. 10.1007\/s11060-020-03487-8","journal-title":"J Neurooncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ajns.AJNS_231_16","article-title":"Subependymal giant cell astrocytoma: associated hyperproteinorrhachia causing shunt failures and nonobstructive hydrocephalus - report of successful treatment with long-term follow-up","volume":"12","author":"Kasper E","year":"2017","unstructured":"Kasper E, Laviv Y, Sebai ME, Lin N, Butler W. Subependymal giant cell astrocytoma: associated hyperproteinorrhachia causing shunt failures and nonobstructive hydrocephalus - report of successful treatment with long-term follow-up. Asian J Neurosurg. 2017, 12:746-50. 10.4103\/ajns.AJNS_231_16","journal-title":"Asian J Neurosurg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2011.09.006","article-title":"Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex","volume":"16","author":"Perek-Polnik M","year":"2012","unstructured":"Perek-Polnik M, J\u00f3\u017awiak S, Jurkiewicz E, Perek D, Kotulska K. Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex. Eur J Paediatr Neurol. 2012, 16:83-5. 10.1016\/j.ejpn.2011.09.006","journal-title":"Eur J Paediatr Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-014-2309-0","article-title":"Persistent communicating hydrocephalus in adult tuberous sclerosis patients: a possible therapeutic role for everolimus","volume":"157","author":"Laviv Y","year":"2015","unstructured":"Laviv Y, Jackson S, Rappaport ZH. Persistent communicating hydrocephalus in adult tuberous sclerosis patients: a possible therapeutic role for everolimus. Acta Neurochir (Wien). 2015, 157:241-5. 10.1007\/s00701-014-2309-0","journal-title":"Acta Neurochir (Wien)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.12.004","article-title":"Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients","volume":"50","author":"Kotulska K","year":"2014","unstructured":"Kotulska K, Borkowska J, Roszkowski M, et al.. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Pediatr Neurol. 2014, 50:307-12. 10.1016\/j.pediatrneurol.2013.12.004","journal-title":"Pediatr Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.08.003","article-title":"The CARE guidelines: consensus-based clinical case report guideline development","volume":"67","author":"Gagnier JJ","year":"2014","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014, 67:46-51. 10.1016\/j.jclinepi.2013.08.003","journal-title":"J Clin Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1751124","article-title":"Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA)","volume":"21","author":"Ebrahimi-Fakhari D","year":"2020","unstructured":"Ebrahimi-Fakhari D, Franz DN. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA). Expert Opin Pharmacother. 2020, 21:1329-36. 10.1080\/14656566.2020.1751124","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-018-3826-6","article-title":"Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex","volume":"34","author":"Fohlen M","year":"2018","unstructured":"Fohlen M, Ferrand-Sorbets S, Delalande O, Dorfm\u00fcller G. Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex. Childs Nerv Syst. 2018, 34:1511-9. 10.1007\/s00381-018-3826-6","journal-title":"Childs Nerv Syst"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2016.11.003","article-title":"Everolimus alleviates obstructive hydrocephalus due to subependymal giant cell astrocytomas","volume":"68","author":"Moavero R","year":"2017","unstructured":"Moavero R, Carai A, Mastronuzzi A, Marciano S, Graziola F, Vigevano F, Curatolo P. Everolimus alleviates obstructive hydrocephalus due to subependymal giant cell astrocytomas. Pediatr Neurol. 2017, 68:59-63. 10.1016\/j.pediatrneurol.2016.11.003","journal-title":"Pediatr Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2024.02.023","article-title":"Navigating uncharted waters: comparative analysis of clinical progression and outcomes in vestibular schwannoma patients with papilledema and without hydrocephalus, versus those without papilledema and hydrocephalus: a comprehensive institutional insight","volume":"184","author":"Chandra Jha V","year":"2024","unstructured":"Chandra Jha V, Jain R, Saran Sinha V, Kumar N, Verma G, Maurya VK. Navigating uncharted waters: comparative analysis of clinical progression and outcomes in vestibular schwannoma patients with papilledema and without hydrocephalus, versus those without papilledema and hydrocephalus: a comprehensive institutional insight. World Neurosurg. 2024, 184:e743-53. 10.1016\/j.wneu.2024.02.023","journal-title":"World Neurosurg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-017-0839-7","article-title":"Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review","volume":"41","author":"Laviv Y","year":"2018","unstructured":"Laviv Y, Kasper BS, Kasper EM. Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review. Neurosurg Rev. 2018, 41:957-68. 10.1007\/s10143-017-0839-7","journal-title":"Neurosurg Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-023-05866-2","article-title":"Hydrocephalus in patients with vestibular schwannoma","volume":"165","author":"Fairhead R","year":"2023","unstructured":"Fairhead R, Harris L, Shoakazemi A, Pollock J. Hydrocephalus in patients with vestibular schwannoma. Acta Neurochir (Wien). 2023, 165:4169-74. 10.1007\/s00701-023-05866-2","journal-title":"Acta Neurochir (Wien)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2011.05.005","article-title":"Development of hydrocephalus and classical hypothesis of cerebrospinal fluid hydrodynamics: facts and illusions","volume":"94","author":"Ore\u0161kovi\u0107 D","year":"2011","unstructured":"Ore\u0161kovi\u0107 D, Klarica M. Development of hydrocephalus and classical hypothesis of cerebrospinal fluid hydrodynamics: facts and illusions. Prog Neurobiol. 2011, 94:238-58. 10.1016\/j.pneurobio.2011.05.005","journal-title":"Prog Neurobiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269510-complex-factors-in-hydrocephalus-development-in-tuberous-sclerosis-complex-a-case-report-of-subependymal-giant-cell-astrocytoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T21:44:34Z","timestamp":1721684674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269510-complex-factors-in-hydrocephalus-development-in-tuberous-sclerosis-complex-a-case-report-of-subependymal-giant-cell-astrocytoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.65132","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,22]]}}}